Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Pfizer management commentary cites non-COVID product growth as driver of Q3 2026 performance

By Public Technologies
  • Pfizer management commentary raised full-year 2026 revenue guidance to $62 billion-$64 billion, citing non-COVID product growth and disciplined execution.
  • Adjusted diluted EPS guidance rose to $2.95-$3.05, absorbing a $0.10-per-share charge related to the Innovent transaction.
  • Third-quarter revenue reached $16.6 billion, exceeding management expectations as non-COVID products grew 7% operationally, offset by lower COVID-19 product revenue.
  • Adjusted diluted EPS reached $0.87, including the $0.10 Innovent charge, with cost discipline and improved productivity supporting earnings.
  • Launched and acquired products generated $3.8 billion in revenue, up 32% operationally, primarily driven by Padcev, Nurtec and Lorbrena.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pfizer Inc. published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.